Ruben de Francisco, Onera Health - Wearable Sleep Diagnostics System | LSI Europe '22

Transcription

Ruben de Francisco  0:07  

Good morning, everyone. Let me talk to you about the great healthcare challenge. So during the past two years, we've seen entire economies fail because our healthcare systems are overloaded. And this happened because we were not able to access health care facilities. And because we have a health care personnel shortage. This showed us that there is a great need for remote diagnostics and monitoring. And this is exactly what we address at Onera in sleep. Our goal is to make sleep diagnostics and monitoring broadly accessible to anyone who needs it, and wherever they are. So today, if you want to be diagnosed for a sleep disorder, you'll go into a sleep lab, and you'll do a polysomnography or PSC study. And that's a gold standard. And it looks like this. So as you can imagine, it's hard to get any sleep with that. And not only is not a great user experience, but it requires a lot of technical supervision is really expensive and is not scalable. And as a result, we see that only a few of those who need to do a sleep study ever do a sleep study. And that's exactly what we want to change. For the first time, we are bringing the sleep lab to your home. And we call it PSGs a service. It's enabled by by device, it's a batch based single use BSD system, they can be very, very easily applied by anyone at home. And he connects with our cloud platform for analysis and reporting. So let me show you what it looks like. We've got a device that's very easy to use, very accurate, and very comfortable. And we can achieve this because we have our own semiconductor technology. We call it the NRI biomedical lab on chip. And for the first time, we were able to bring all of the signals that you need in a sleep lab into just one single chip. And so all of these data goes into the underlying cloud. And that cloud, a clinician or a doctor can very easily request a sleep study. It includes analytics and reporting. So that is very easily accessible as well by the clinician, which makes it very scalable so that we can reach any patient in need of a sleep diagnostics study. So how does it work? It's a very easy process, a slip daughter goes into the platform, request the study, through the platform owner delivers the sensors to the patient, the patient conducts the study, and returns the sensors to an era on error, make sure that the data is analyzed, and the report is sent back to the referring doctor and the doctor finalizes the diagnosis or initiates therapy where needed. So basically, a process that could take weeks or months can can be done now in just a few days. So so far, we were able to release the gen one of this big as a service offering. And it's enabled by a first generation device which is the owner STS. So let me show you what it looks like. Its just as simple as taking a patch and clicking a center. It looks easy, doesn't it? And it's really, really easy. It is four sensors, of which there's two of them, the head patch and the test spot collect most of the data that we need for an accurate measurement of the brain function. The cardiac function the respiratory function, is the first big system has no wires can be applied in less than five minutes. And it contains the entire polysomnography signal set. We've obtained the CE mark for the products. And recently this year we obtained the FDA clearance for the US and it's a very strong clearance because we managed to prove substantial equivalence against the gold standard PhD system that used today, traditional PhD system in a lab. And the market really needs us there are over a billion adults today with a sleep disorder and 80% of them remain undiagnosed. And there is good news though, which is that the market has seen the importance of sleep And we are seeing the global state testing market grow up to an estimated $13 billion by 2027. With double digit growth. So where do we fit as an era in this huge market? Well, our roots come from being actually both a med tech company and a deep tech company. We've got our own semiconductor technology in house. And in fact, we are a spinoff from IMEC, the leading R&D Institute in nanotechnology and digital technologies. But not only did we start with a great network of technology partners, and clinical partners, but we are very lucky to have strong investors supporting us from day one. And we've extended these investors over time with additional VCs from Europe, the US and Asia. And this allowed us even as a young company to achieve great success and great recognition and awards. And just to name a few. The Frost and Sullivan Best Practices award for a company and the Red Dot Design Awards that we obtained for a product we chose how patient centric a product is. So where do we stand today, we've got a device that smarts and FDA cleared our proprietary system on chip and a cloud platform. We've raised over 25 million euros to date. We have a very strong team with over 40 employees in multiple geographies and a broad patent and publication portfolio. And so with this, we were able to launch our first generation of the PSG as a service solution in Europe and in the US. And now we are ready to take it to the next level. So today here we are starting our Series C investment rounds, we raising 20 million to expand commercialization of our Gen one solution in Europe and in the US and to launch our Gen one solution in volume. If you'd like to join in our journey to make sleep diagnostics broadly accessible to anyone, anywhere join us. Thank you